牛牛AI助理已提取核心訊息
Cassava Sciences, Inc., a biotechnology company based in Austin, Texas, has announced the registration of warrants for purchase of its common stock with the United States Securities and Exchange Commission (SEC). These warrants, expiring on or before November 15, 2024, will be distributed to shareholders of record as of December 22, 2023. The distribution of the warrants is set to occur on or about January 3, 2023. Each warrant entitles the holder to purchase shares of Cassava Sciences' common stock at a price of $33.00, along with an additional 0.5 share per warrant exercised before the Bonus Share Expiration Date. The company has applied to list these warrants on The Nasdaq Capital Market under the symbol 'SAVAW'. Cassava Sciences has also outlined the conditions under which the warrants...Show More
Cassava Sciences, Inc., a biotechnology company based in Austin, Texas, has announced the registration of warrants for purchase of its common stock with the United States Securities and Exchange Commission (SEC). These warrants, expiring on or before November 15, 2024, will be distributed to shareholders of record as of December 22, 2023. The distribution of the warrants is set to occur on or about January 3, 2023. Each warrant entitles the holder to purchase shares of Cassava Sciences' common stock at a price of $33.00, along with an additional 0.5 share per warrant exercised before the Bonus Share Expiration Date. The company has applied to list these warrants on The Nasdaq Capital Market under the symbol 'SAVAW'. Cassava Sciences has also outlined the conditions under which the warrants can be redeemed and the adjustments applicable to the Basic Warrant Exercise Rate and the Bonus Share Expiration Trigger Price. The company will provide public notice prior to any redemption or expiration event related to the warrants. The distribution of the warrants is part of a dividend issuance and has not been registered under the Securities Act, with the company planning to file a prospectus supplement for the shares of common stock underlying the warrants.
總部位於德克薩斯州奧斯汀的生物技術公司Cassava Sciences, Inc. 宣佈在美國證券交易委員會（SEC）註冊購買其普通股的認股權證。這些認股權證將於2024年11月15日當天或之前到期，將分配給截至2023年12月22日的登記股東。認股權證的分配定於2023年1月3日左右進行。每份認股權證使持有人有權以33.00美元的價格購買Cassava Sciences的普通股，並在紅股到期日之前行使的每份認股權證額外購買0.5股。該公司已申請在納斯達克資本市場上市，股票代碼爲 “SAVAW”。Cassava Sciences還概述了贖回認股權證的條件以及適用於基本認股權證行使率和紅股到期觸發價格的調整。公司將在與認股權證相關的任何贖回或到期事件之前發佈公告。認股權證的分配是股息發行的一部分，尚未根據《證券法》進行登記，該公司計劃提交認股權證所依據普通股的招股說明書補充文件。
總部位於德克薩斯州奧斯汀的生物技術公司Cassava Sciences, Inc. 宣佈在美國證券交易委員會（SEC）註冊購買其普通股的認股權證。這些認股權證將於2024年11月15日當天或之前到期，將分配給截至2023年12月22日的登記股東。認股權證的分配定於2023年1月3日左右進行。每份認股權證使持有人有權以33.00美元的價格購買Cassava Sciences的普通股，並在紅股到期日之前行使的每份認股權證額外購買0.5股。該公司已申請在納斯達克資本市場上市，股票代碼爲 “SAVAW”。Cassava Sciences還概述了贖回認股權證的條件以及適用於基本認股權證行使率和紅股到期觸發價格的調整。公司將在與認股權證相關的任何贖回或到期事件之前發佈公告。認股權證的分配是股息發行的一部分，尚未根據《證券法》進行登記，該公司計劃提交認股權證所依據普通股的招股說明書補充文件。
有用
沒用